Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 90 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 7696159

    Treatment for basal cell carcinoma

    Graceway Pharmaceuticals. LLC · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted

  2. US 7691832

    Methods of treatment of inflammatory diseases

    The Board of Regents of the University of Oklahoma · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted

  3. US 7691380

    Combined methods for tumor coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted

  4. US 7678552

    Method for selecting therapeutic agents for cancer treatment

    Precision Therapeutics, Inc. · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted

  5. US 7678824

    Methods for treatment with bucindolol based on genetic targeting

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted

  6. US 7670855

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted

  7. US 7666581

    Methods for preparing compositions comprising heat shock proteins useful for the treatment of cancer and infectious disease

    University of Connecticut Health Center · Granted Feb 23, 2010 · Expires Feb 18, 2030

    granted

  8. US 7666886

    Compounds and methods for the diagnosis and treatment of amyloid associated diseases

    The Regents of the University of California · Granted Feb 23, 2010 · Expires Feb 18, 2030

    granted

  9. US 7662999

    Recognition of oligosaccharide molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseases

    The United States of America as represented by the Department of Health and Human Services (DHHS) · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  10. US 7655694

    Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted

  11. US 7655472

    Treatment of disease by inducing cell apoptosis

    The Regents of the University of California · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted

  12. US 7648695

    Medicaments for chemotherapeutic treatment of disease

    Provectus Pharmatech, Inc. · Granted Jan 19, 2010 · Expires Jan 14, 2030

    granted

  13. US 7648701

    Peptide composition as immunogen for the treatment of allergy

    United Biomedical, Inc. · Granted Jan 19, 2010 · Expires Jan 14, 2030

    granted

  14. US 7638501

    Method of treatment of mitochondrial disorders

    The Regents of the University of California · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  15. US 7638507

    Compositions for treatment of inflammatory diseases

    The Board of Regents of the University of Oklahoma · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  16. US 7625563

    Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted

  17. US 7622461

    Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders

    ACADIA Pharmaceuticals Inc. · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

  18. US 7622118

    Cancer treatment methods using selected antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

  19. US 7619000

    S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer

    The Board of Regents of the University of Texas System · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted

  20. US 7612107

    Treatment and inhibition of disease conditions using flexible heteroarotinoids

    The Board of Regents of the University of Oklahoma · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted

  21. US 7601516

    Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility

    Syntonix Pharmaceuticals, Inc. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  22. US 7585852

    Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation

    Solidago AG · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted

  23. US 7582289

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted

  24. US 7579188

    Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury

    The Regents of the University of California · Granted Aug 25, 2009 · Expires Aug 20, 2029

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.